Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer
对既往接受过治疗的转移性乳腺癌患者进行奈拉替尼联合卡培他滨与拉帕替尼联合卡培他滨治疗的III期NALA研究的生物标志物分析
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-1584
Saura, Cristina; Matito, Judit; Oliveira, Mafalda; Wildiers, Hans; Brufksy, Adam M; Waters, Simon H; Hurvitz, Sara A; Moy, Beverly; Kim, Sung-Bae; Gradishar, William J; Queiroz, Geraldo Silva; Cronemberger, Eduardo; Wallweber, Gerald J; Bebchuk, Judith; Keyvanjah, Kiana; Lalani, Alshad S; Bryce, Richard; Vivancos, Ana; Eli, Lisa D; Delaloge, Suzette
